Menu principale:
Servizi online
Un elenco aggiornato di molecole e dispositivi medici in sperimentazione nel mondo
Meccanismo |
Nome molecola |
Via di somministrazione |
Fase Studio |
Sponsor |
Onicomicosi | ||||
Terapia Laser | Diode Laser | Studio clinico | ConBio, a Cynosure Company | |
Antifungino | Luliconazolo | Topica |
II/III |
Topica Pharmaceuticals |
Nuova molecola | MOB015B |
III |
Moberg Pharma AB | |
Nuova molecola | NVXT | Topica |
II |
Taro Pharmaceuticals USA |
Antifungino | Efinaconazolo |
IV |
Valeant Pharmaceuticals International, Inc. | |
Nuova molecola | P-3058 | Topica |
III |
Polichem S.A. |
Antifungino | CELEXT07 | Topica |
II |
9305-9954 Quebec Inc |
Laser | CURE-EX |
IV |
MB Mazor Ltd. | |
Laser | 1,064nm Long-pulsed Nd:YAG |
IV |
Mahidol University | |
Tinea | ||||
Antifungino |
Luliconazolo Product 33525 |
Topica |
IV |
Valeant Pharmaceuticals International, Inc. |
Estratto vegetale |
Ginkgo Biloba Glucosamina solfato
|
Topica Orale |
I |
Ahmed A. H. Abdellatif |
Ormone |
S2G6T-1 S2G6T-2 |
Topica |
II Studio clinico |
Sol-Gel Technologies, Ltd. |
Mollusco contagioso | ||||
Potassio Idrossido | Topica |
II/III |
Jordi Gol i Gurina Foundation | |
Screening | Teledermatologia |
II |
Centro Studi GISED | |
Estratto vegetale | East Indian sandalwood oil (EISO) | Topica |
II |
ViroXis Corporation |
Leishmaniosi cutanea | ||||
Sodio Stibogluconato | Intravenosa | II Studio clinico |
U.S. Army Medical Research and Materiel Command | |
Antineoplastico | Miltefosine |
II |
Paladin Labs (USA) Inc. | |
Antimonio |
II/III |
Oswaldo Cruz Foundation | ||
Calore | Heat pack conduction-heat therapy | Studio clinico | Universidad Peruana Cayetano Heredia | |
Vaccino | LEISH-F3 | Intramuscolare |
I |
Infectious Disease Research Institute |
Impetigine | ||||
Antibiotico | Retapamulin (Altabax) | Topica |
IV |
The University of Texas Health Science Center, Houston |
Antibiotico | Ozenoxacin | Topica |
III |
Ferrer Internacional S.A. |
Infezioni cutanee | ||||
Antibiotico | Ceftaroline Fosamil | Intravenosa |
III |
AstraZeneca |
Antibiotico | Oritavancin | Intravenosa | III Studio clinico |
The Medicines Company |
Antibiotico | AFN-12520000 | Orale |
II |
Affinium Pharmaceuticals, Ltd |
Antibiotico | Dalbavancin | Intravenosa |
III |
Durata Therapeutics, Inc. |
Antibiotico |
Daptomicina |
Intravenosa |
IV |
Cubist Pharmaceuticals |
Antibiotico |
TR-701 FA |
Orale |
Trius Therapeutics, Inc |